Reuters logo
BRIEF-Redhill Biopharma to allow multiple sclerosis patent in Japan
October 18, 2016 / 12:37 PM / a year ago

BRIEF-Redhill Biopharma to allow multiple sclerosis patent in Japan

Oct 18 (Reuters) - Redhill Biopharma Ltd -

* Redhill Biopharma announces allowance of a patent in Japan supporting RHB-104 for multiple sclerosis

* Top-line final results expected in coming weeks from phase IIA proof-of-concept study evaluating RHB-104

* Safety-Focused independent data and safety monitoring board meeting is on track to take place in Q4 of 2016 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below